Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biomed Res Int ; 2019: 5301405, 2019.
Article in English | MEDLINE | ID: mdl-30941365

ABSTRACT

AIM: To assess the systemic and local immunological response to subcutaneous implants of a vascular graft covered with collagen extracted from the European carp (freshwater fish) or with collagen of bovine origin. METHODS: Pieces of a vascular graft covered by pure bovine (Bos taurus, BOV, n=14) or carp (Cyprinus carpio, CYP, n=14) collagen 5 mm in size were implanted subcutaneously in the dorsum of a Balb/cOla mice. A sham operation group of 12 animals served as the control. At 7 and 14 days after the operation, one-half of each group was terminated and blood for serum, spleen, and implant with surrounding tissue were collected. Mean cytokine (TNF-α, IL-10, IL-4, IL-1ß, IL-13, and IFN-γ) levels in serum were determined using ELISA. Spleen cell cultures were used for in vitro testing of lymphocyte proliferation and cytokine secretion. Local expressions of IL-6, IL-10, TNF-α, TGF-ß, CCL-2, and CCL-3 were determined using PCR. RESULTS: We found no significant difference among control, BOV, and CYP groups in mean cytokine serum levels at seven days. At day 14, the BOV group had higher levels of TNF-α (P=.018) and both the BOV and CYP groups had lower levels of IL-4 (P=.011 and P=.047, respectively) compared with the control group. Both tested implants showed only a minimal effect on the production of selected cytokines. Cell proliferation in the CYP group stimulated by CYP gel at 14 days was significantly lower than by BOV gel in BOV group (P=.0031) or by CYP gel in the control group (P=.041). The difference between the groups in the local RNA expression of all the tested mediators both at 7 and at 14 days was not significant apart from a lower level of TNF-α in the BOV group compared to CYP at 14 days (P=.013). CONCLUSIONS: Implants covered with carp collagen induce an immunological response that is comparable to that of bovine collagen covered implants in a mouse model.


Subject(s)
Blood Vessel Prosthesis , Collagen/immunology , Animals , Carps , Cattle , Cell Proliferation , Cellular Microenvironment , Cytokines/blood , Mice, Inbred BALB C , RNA, Messenger/genetics , RNA, Messenger/metabolism , Spleen/cytology
2.
Folia Microbiol (Praha) ; 58(2): 111-21, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22875593

ABSTRACT

Mucosal immunization with non-living antigens usually requires the use of an adjuvant. The adjuvant activity of Bacillus firmus in the mucosal immunization of mice was described by our laboratory previously. In the present study, subcellular localization of B. firmus activities was followed. After mechanical disintegration, subcellular components of bacterium were fractionated by differential centrifugation and salting out. Bacterial cell walls, cytoplasmic membrane fraction, soluble cytoplasmic proteins, and ribosomal fractions were isolated. Their effect on the mouse immune system was studied. Lymphocyte proliferation and immunoglobulin formation in vitro were stimulated by bacterial cell wall (BCW), cytoplasmic membrane (CMF), and ribosomal fractions. BCW and CMF increased antibody formation after intratracheal immunization of mice with influenza A and B viruses, and increased protection against subsequent infection with influenza virus. The BCW fraction even induced intersubtypic cross-protection: Mice immunized with A/California/7/04 (H3N2) + BCW were resistant to the infection by the highly pathogenic A/PR/8/34 (H1N1) virus.


Subject(s)
Adjuvants, Immunologic/isolation & purification , Bacillus/chemistry , Adjuvants, Immunologic/administration & dosage , Animals , Antibody Formation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Disease Models, Animal , Influenza A virus/immunology , Influenza B virus/immunology , Influenza Vaccines/administration & dosage , Lymphocytes/drug effects , Mice , Orthomyxoviridae Infections/prevention & control
3.
Immunol Lett ; 134(1): 26-34, 2010 Nov 30.
Article in English | MEDLINE | ID: mdl-20709105

ABSTRACT

Due to the persisting threat of development of new highly pathogenic influenza A subtypes, a mucosal vaccination which would induce a potent and cross-protective reaction is desirable. We succeeded in mucosal immunization of mice with an inactivated influenza A virus by using delipidated Bacillus firmus (DBF) as adjuvant. The mechanism of adjuvant effect was followed in NALT by comparing the response after intranasal immunization by inactivated influenza virus type A (H1N1) alone, adjuvant alone (DBF), or by a mixture of virus+DBF. Expression of selected gene groups was tested via qPCR at 7 different time-points: cytokines (IL-2, IFN-γ, IL-4, IL-6, and IL-10), type I interferons (IFN-α4, IFN-α11, IFN-α12, and IFN-ß), toll-like receptors (TLR2, TLR3, TLR7, and TLR9), iNOS and CCR7. Intranasally administered DBF and the mixture of virus+DBF induced an elevated expression of IFN-γ, IL-6 and IL-10 cytokines, type I interferons, iNOS, and pDC markers in NALT. Multimarker qPCR data was analyzed by relative quantification and by principal component analysis. DBF has been shown to be a very efficient adjuvant for the stimulation of innate immunity after IN immunization. DBF accelerated, increased, and prolonged the antiviral response.


Subject(s)
Bacillus/immunology , Cytokines/genetics , Influenza A Virus, H1N1 Subtype/immunology , Lymphoid Tissue/metabolism , Nasopharynx/metabolism , Toll-Like Receptors/genetics , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Animals , Drug Synergism , Gene Expression/drug effects , Immunization/methods , Influenza Vaccines/administration & dosage , Influenza Vaccines/immunology , Interferon Type I/genetics , Interleukin-10/genetics , Interleukin-2/genetics , Membrane Glycoproteins/genetics , Mice , Mice, Inbred BALB C , Principal Component Analysis , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Toll-Like Receptor 2/genetics , Toll-Like Receptor 3/genetics , Toll-Like Receptor 7/genetics , Toll-Like Receptor 9/genetics
4.
Immunol Lett ; 115(2): 144-52, 2008 Jan 29.
Article in English | MEDLINE | ID: mdl-18160106

ABSTRACT

Mucosal immunization by inactivated viruses often fails to evoke a sufficient immune response. Intensive efforts have been made to enhance the response by suitable adjuvants. We used the G+ nonpathogenic delipidated bacterium Bacillus firmus with pronounced immunostimulatory properties as an adjuvant for immunizing mice with inactivated influenza virus type A. BALB/c mice were immunized intratracheally with inactivated influenza A H1N1 and H3N2 viruses. The production of antibodies in sera and secretions was determined by the ELISA. The local situation in the lungs was assessed histologically and by testing the cytokine expression. The protective and cross-protective effect against infection was tested in in vivo experiments after infection with influenza virus A H1N1. B. firmus as adjuvant increased both systemic and mucosal antibody responses, improved protection against homologous virus and induced cross-protection against virus H1N1 after immunization with virus H3N2.


Subject(s)
Adjuvants, Immunologic , Antibodies, Viral/immunology , Bacillus/immunology , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H3N2 Subtype/immunology , Influenza Vaccines/immunology , Influenza, Human/immunology , Animals , Antibodies, Viral/blood , Cross Reactions , Cytokines/biosynthesis , Cytokines/immunology , Female , Humans , Immunity, Mucosal , Immunization , Influenza, Human/mortality , Influenza, Human/prevention & control , Influenza, Human/virology , Lung/immunology , Lung/pathology , Mice , Mice, Inbred BALB C , Orthomyxoviridae Infections/immunology , Orthomyxoviridae Infections/mortality , Orthomyxoviridae Infections/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...